Aspen Neuroscience, Inc. (ASPE)
NASDAQ: ASPE · Real-Time Price · USD
13.82
+1.01 (7.88%)
At close: Nov 11, 2026, 4:00 PM EST
13.51
-0.31 (-2.24%)
Pre-market: Nov 12, 2026, 5:41 AM EST
Aspen Neuroscience Market Cap
Aspen Neuroscience has a market cap or net worth of $401.87 million as of November 11, 2026. It is the 16,009th most valuable company in the world and the 2,893rd biggest in the United States.
Market Cap
401.87M
Enterprise Value
339.26M
1-Year Change
n/a
Global Rank
Country Rank
#2,893 United States
Category
ChartMarket Cap Chart
Since the IPO on October 30, 2026, Aspen Neuroscience's market cap has decreased from $436.18M to $401.87M, a decrease of -7.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 401.87M | 7.88% |
| Nov 10, 2026 | 372.50M | 3.31% |
| Nov 9, 2026 | 360.57M | -0.32% |
| Nov 6, 2026 | 361.74M | 5.78% |
| Nov 5, 2026 | 341.96M | -7.84% |
| Nov 4, 2026 | 371.04M | 3.82% |
| Nov 3, 2026 | 357.38M | -5.75% |
| Nov 2, 2026 | 379.18M | -13.07% |
| Oct 30, 2026 | 436.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 410.77M |
| Alector | 409.41M |
| Prelude Therapeutics | 397.56M |
| ARS Pharmaceuticals | 388.04M |
| SL Science Holding | 387.78M |
| C4 Therapeutics | 380.82M |
| Altimmune | 378.34M |
| Fennec Pharmaceuticals | 376.45M |